为了改善CRL4CRBN的Degron阻止策略招募PROTAC选择性
Habib Bouguenina1, Andrea Scarpino1, Jack A O'Hanlon1
1Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK.
开发向蛋白质降解剂需要高度选择性. 这项研究修改了分子合剂以消除不必要的降解,增强了PROTAC的选择性,而不妨碍目标参与,为药物开发提供了新的工具.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 诱导蛋白质降解的小分子是关键的药理学工具和新兴的临床药剂.
- 在这些分子中实现选择性是它们充分发挥潜力的重大挑战.
- 招募CRL4CRBN的PROteolysis T向金马 (PROTACs) 经常通过新基质招募表现出内在的单价降解.
研究的目的:
- 为了解决CRL4CRBN-招募PROTAC设计中的选择性挑战.
- 为了减弱或消除已知的CRL4CRBN分子的单价降解功能.
- 通过应用新的设计原则,生成具有改进的选择性配置的PROTAC.
主要方法:
- 利用CRL4CRBN新基质的结构洞察力.
- 已知的CRL4CRBN分子剂 (CC-885,Pomalidomide) 经过修改以阻止新基质结合.
- 将设计原理应用于BRD9 PROTAC (dBRD9-A),以创建一个选择性模拟器.
- 利用计算建模来评估三元复杂的形成.
主要成果:
- 成功地减弱和删除了CC-885和Pomalidomide的单价降解功能.
- 产生了一个BRD9 PROTAC模拟器,具有明显改进的选择性概况.
- 计算机建模证实,阻断降解的设计不会阻碍PROTAC诱导的三元复合体形成.
结论:
- 提出的设计原则提供了一种策略,通过减轻非目标降解来提高PROTAC的选择性.
- 开发的工具和方法可以帮助设计更有选择性的向蛋白质降解剂.
- 这项工作有助于推进治疗应用的向蛋白质降解领域.
更多相关视频
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
相关概念视频
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Regioselectivity of Electrophilic Additions to Alkenes: Markovnikov's Rule
The hydrohalogenation of an unsymmetrical alkene can yield two haloalkane products, depending on which vinylic carbon takes up the halogen. However, one product usually predominates, where hydrogen adds to the vinylic carbon bearing the...
Regioselectivity and Stereochemistry of Hydroboration
Hydroboration proceeds in a concerted fashion with the attack of borane on the π bond, giving a cyclic four-centered transition state. The –BH2 group is bonded to the less substituted carbon and –H to the more substituted carbon. The concerted nature requires the simultaneous addition of –H and –BH2 across the same face of the alkene giving syn...
Radical Anti-Markovnikov Addition to Alkenes: Overview
Prochirality
GPCR Desensitization
